Transdermal delivery of ibuprofen and its prodrugs by passive diffusion and iontophoresis

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue SUPPL. 1, 2010, Pages 79-85

  Ghosh, Bijaya ^a   Preethi, G B ^a   Mishra, Roopak ^b   Parcha, Versha ^b  

^a A Constituent Unit of KLE Academy of Higher Education Research   (India)

^b Sardar Bhagwan Singh Post Gratudate Institute of Biomedical Sciences & Research   (India)

Author keywords

Ibuprofen; Iontophoresis; Prodrug; Transdermal

Indexed keywords

2,4, ISOBUTYL PHENYL ETHYL PROPIONATE; IBUPROFEN; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG PENETRATION; DRUG SYNTHESIS; ESTERIFICATION; IN VITRO STUDY; IONTOPHORESIS; NONHUMAN; SKIN PERMEABILITY;

EID: 77953427178     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Henk S, Jaco CB, Jonathan H, Jeanetta du P. Synthesis and transdermal penetration of NSAID glycoside esters. Int J Pharm 2005; 301: 71-79.
2. Peng W, Meiling Q, Lihe L, Lin F. Determination of ibuprofen in dog plasma by liquid chromatography and application in pharmacokinetic studies of an ibuprofen prodrug in dogs. J Pharm Biomed Anal 2005; 38: 714-719.
3. Nithar RC, Amol AK, Santosh PG. Synthesis, pharmacological activity and hydrolytic behavior of ethylenediamine and benzathine conjugates of ibuprofen. Eur J Med Chem 2007; 20: 1-5
4. Francesco P B, Carmelo P, Tony B, Paolo de C, Francesco P, Maria G R, Antonella S. In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac. Eur J Pharm Sci 2001; 14: 123-134.
5. Xiangguo Z, Xinyi T, Dongzhi W, Qingxun. Pharmacological activity and hydrolysis behavior of novel ibuprofen glucopyranoside conjugates. Eur J Med Chem 2006; 41: 1352- 1358
6. Mirzaagha B. Synthesis and study of controlled release of ibuprofen from the new acrylic type polymers. Int J Pharm 2006; 316: 68-73.
7. Xiuli Z, Dawei C, Ping G, Pingtian D, and Kexin. Synthesis of ibuprofen eugenol ester and its Microemulsion Formulation for Parenteral Delivery. Chem Pharm Bull53(10) 1246-1250 (2005).
8. J Aukunuru1, C Bonepally and V Guduri. Preparation, characterization and optimization of ibuprofen ointment intended for topical and systemic delivery. Trop J Pharmaceut Res 2007; 6 (4): 855-860.
9. Paul WS, Adrian CW and Brian WB. Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J Contr Release 1998; 50: 297-308.
10. SE Cross and MS Roberts. Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Curr Drug Deliv 2004; 1: 81-92.
11. H-Y Thong, H Zhai, H I Maibach. Percutaneous penetration enhancers: an overview. Skin Pharmacol Physiol 2007; 20:272- 282.
12. Heather AE, Benson. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2005; 2:23-33.
13. Barry BW, Bennett SL. Effect of penetration enhancers on the permeaton of mannitol hydrocortisone and progesterone through human skin. J Pharm Pharmacol 1987; 39:535-546.
14. Guang Yan, S Kevin Li, William IH. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery. J Contr Release 2005; 110:141-150.
15. Eugene RV, and Thomas AW. Iontophoresis: The process behind noninvasive drug delivery. Regional Anesthesia and Pain Medicine 2005; 30: 292-29.
16. RH Guy, MB Delgado-Charro, YN Kalia. Iontophoretic transport across the skin. Skin Pharmacol Appl Skin Physiol 2001; 14:35-40.
17. RK Khar and A Nanda, Iontophoretic drug delivery, in: Controlled and novel drug delivery system, N.K. Jain, ed., C.B.S. Publishers and Distributors, New Delhi, 2005; 191-207.
18. Nitin D, Vikas B, Sanjula B, Alka A and Javed A. Iontophoresis - An approach for controlled drug delivery: A Review. Curr Drug Deliv 2007; 4: 1-10.
19. rd ed. Newyork: A Wiley interscience publications; 2004. p.240,348-351.
20. 12th ed. London: pharmaceutical press; 1994. p.908.
21. Estelle B, Jeanetta P, Douw GM, Colleen G, Francois JR. The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID's on their transdermal absorption. Int J Pharm 2000; 193:261-264.
22. Chongxi YU, Lina XU, WIPO: Pub.No: (WO/2008/010025) Positively charged water-soluble prodrugs. http://www.wipo.int/portal/index.html.en
23. Jinying L, Weiya Z, Adrian J, Michael D. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomized controlled trials. BMJ, 2004; 329:324.
24. Vrinda R. Shanbhag, A. Michael C, Rajeev G, Anju H, Ronald MD. Ester and amide prodrugs of ibuprofen and naproxen; synthesis, ant-inflammatory activity and gastrointestinal toxicity. J Pharm Sci 1992; 81:249-154.
25. Therapeutic outcome confirmed for transdermal ibuprofen, pharmalicencing.com; TransDermal Technologies, Inc. PressRelease issued 5th February 2002.
26. Abha D, Deshpande SG. In vivo pharmacokinetic studies of prodrugs of ibuprofen. Indian J Pharmaceut Sci 2007; 69:824- 827.
27. th ed. Newyork: Mc Graw Hill; 2006. p. 699.
28. Eun-Seok P, Si-Young C Mikyoung H, Sang-Cheol Chi. Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int J Pharm 2000; 209:109-119.
29. Waranis RP, Sloan KB. Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: bisacyloxymethyl-6-mercaptopurine prodrugs. J Pharm Sci 1987; 76: 587-95.
30. Doh HJ, Cho WJ, Yong CS, Choi HG, Kim JS, Lee CH, Kim DD. J. Synthesis and evaluation of ketorolac ester prodrugs for transdermal delivery. Pharm Sci 2003; 92: 1008-17.
31. Belagali SL, Himaja M. Synthesis and evaluation of anti-inflamamtory activity of 2-(4 isobutyl phenyl) propionyl derivatives of amino acids and peptides. Ind J Chem 1991; 38: 505-507.
32. Bonina FP, Rimoli MG, Avallone L, Barbato F, Amato M, Puglia C. et al. New oligoethylene ester derivatives of 5-iodo-2'-deoxyuridine as dermal prodrugs: synthesis, physicochemical properties, and skin permeation studies. J Pharm Sci 2002; 91: 171.
33. Kenneth AW and Keith RB. Topical and Transdermal delivery. In: Mark Gibson editor. Pharmaceutical preformulation and formulation - A practical guide for candidate drug selection to commercial dosage form. 2nd ed. Newyork: CRC press; 2004. p.536
34. Watson DG. Pharmaceutical Analysis, Elsevier Publishers: London, 2005. p.34
35. Rautio, J, Taipale H, Gynther J, Vepsalainen J, Nevalainen T, Jarvinen T. In vitro evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen. J Pharm Sci 1998; 87:1622.
36. Lipp R, Laurent H, Gunther C, Riedl J, Esperling P, Tauber U. Prodrugs of gestodene for matrix-type transdermal drug delivery systems. Pharm Res 1998; 15: 1419-24.
37. Jeng-Fen H, Sunga KC, Oliver YH, Jhi-Joung W, Yi-Hsin L, Jia-You F. The effects of electrically assisted methods on transdermal delivery of nalbuphine benzoate and sebacoyl dinalbuphine ester from solutions and hydrogels. Int J Pharm 2005; 297:162-171.
38. Anroop B, Ghosh B, Parcha V, Khanam J. Transdermal delivery of atenolol: Effect of prodrugs and iontophoresis. Curr Drug Deliv 2009; 6: 280-290.
39. Guy RH, Kalia YN, Delgado-Charro MB, Merino V, Lopez A, Marro D. Iontophoresis: electrorepulsion and electroosmosis. J Control Release 2000; 64: 129-32.
40. Michael JP. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev 2001; 46: 281-305.